Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 24, 2024 12:55pm
RE:Management
Reading the financial report you're absolutely right. But the reality is that the company does not run out of money, even though it should if we just read the financials. I'm not
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Jun 24, 2024 8:17am
Management
What the hell is going on. Nobody answered in this f.......company. We need to know what is going on without money
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 21, 2024 4:20pm
RE:RE:No money
Did you retailers just wake up to this? The market has been telling you this for years and for years you have listened to that pim.p Bioruns like he was a sirona gawd. Best lessons learned are the
...more
(2097)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jun 21, 2024 10:17am
RE:No money
The only reason anyone is still here, hope for a miracle.
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Jun 21, 2024 10:15am
No money
Even if there is a forced sale due to insolvency, I believe that a buyer will be found who is prepared to pay more than the current market value of €9mio. So no risk, despite the tight cash flow
...more
(2097)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jun 21, 2024 10:02am
RE:RE:Fins on sedar
The only good thing is that few want to sell below 5 cents. Other than that, not much to get excited about.
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Jun 21, 2024 2:53am
RE:Fins on sedar
So still no major order for the tfc1067 launch... Then we really will have to wait until 2025
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 20, 2024 11:26pm
Fins on sedar
Revenue $11, 073. Worst MD&A on the TSXV
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 20, 2024 2:44pm
RE:RE:RE:RE:RE:This sounds pretty good to me
From: Michelle Seltenrich Date: October 6, 2022 at 12:10:20PM MDT To: xxxxxxxx Subject: RE: Non-disclosure is Sirona's choice "Abbvie is not
...more
(75)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jun 20, 2024 2:17pm
RE:RE:RE:RE:RE:RE:This sounds pretty good to me
That's why third party clinical trials are done so I'm confident the science is solid. Management on the other hand is the opposite of solid.
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 20, 2024 1:19pm
RE:RE:RE:RE:RE:This sounds pretty good to me
How about this for a conspiracy theaory? The science is just no good.
(1156)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 20, 2024 10:43am
RE:RE:RE:RE:This sounds pretty good to me
Maybe AbbVie bought it just for that express thought of putting it on the shelf for a considerable period of time. Keep it out of the market while they market something else. Why not a conspiracy
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 20, 2024 10:26am
RE:RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
This informal slide was excempted in the official Investor Presentation. Not sure why. Have you asked them now?
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 20, 2024 1:13am
RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Why the hell didn't Stonegate do a share price valuation based on Sirona's financial forecast? (See image). Did mgmt even share this info with Stonegate?
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden